Results

1 - 7 of 7
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
The pharmacokinetics of steady-state oral sustained-release morphine sulphate (OSRMS) were studied in dogs. Beagles (n = 6) were randomly assigned to one of two treatment groups. Treatments included 15 mg OSRMS every 8 h for 4 days, or 15 mg OSRMS every 12 h for 4 days. Serum samples, drawn at inter...
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
Isoflurane is the most recently available inhalational anaesthetic agent on the market. Although there have been few clinical trials comparing its use to halothane and methoxyflurane, the pharmacology of the agent suggests certain situations in which it may be the preferred agent. These include avia...
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
The pharmacokinetics of single-dose morphine sulphate (MS) administered intravenously (i.v.) and intramuscularly (i.m.) and of oral sustained-release morphine sulphate (OSRMS) were studied in dogs. Beagles (n = 6) were randomly assigned to six treatment groups using a Latin square design. Treatments...
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
This study investigated the pharmacokinetics of morphine sulphate in an injectable chitosan-based gel. Gels were made from a combination of N-O-carboxymethylchitosan (NOCC) and chitosan and were easily injectable via a 22 gauge needle and appeared stable during long-term storage. Groups of six beagl...
[Page generation failure. The bibliography processor requires a browser with Javascript enabled.]
The pharmacokinetics and bioavailability (F) of single dose sustained release morphine sulfate (OSRMS) and nonsustained release morphine sulfate (NSRMS) were compared to each other and to a bolus injection of morphine sulfate (MS) intravenously (i.v.) in dogs. Beagles (n = 6) were randomly assigned ...